**Question:** Tetanus prophylaxis for contaminated wound in a partially immune person is

A. Tetanus Toxoid (TT)
B. Tetanus Toxoid (TT) with Intravenous Human Immune Globulin (IV-HIG)
C. Intradermal Tetanus Toxoid (ITT)
D. Intramuscular Inactivated Polio Vaccine (IPV)

**Correct Answer:** B. Tetanus Toxoid (TT) with Intravenous Human Immune Globulin (IV-HIG)

**Core Concept:**
Tetanus is a severe, life-threatening neurological disease caused by the bacterium Clostridium tetani. Tetanus toxoid (TT) is a preventive measure against tetanus, as it stimulates the immune system to produce tetanus-specific antibodies. In partially immune individuals, i.e., those with a history of previous tetanus vaccination, the use of intravascular human immune globulin (IV-HIG) is essential to boost the immune response and provide additional protection against tetanus.

**Why the Correct Answer is Right:**
For a partially immune individual with a history of previous tetanus vaccination, using Tetanus Toxoid (TT) alone may not be sufficient to produce an adequate immune response and protect against tetanus. This is because the individual's immune system has already encountered the tetanus toxoid and produced some antibodies. However, the antibodies are not sufficient enough to provide complete protection in case of tetanus infection.

**Why Each Wrong Option is Incorrect:**

A. Intradermal Tetanus Toxoid (ITT) is incorrect because it is less effective compared to Intramuscular Tetanus Toxoid (IM TT). Intramuscular administration ensures a higher concentration of tetanus toxoid at the site of action (muscle tissue) and accelerates the production of protective antibodies.

B. Intramuscular Inactivated Polio Vaccine (IPV) is incorrect because IPV is a different vaccine, not specifically designed for tetanus prophylaxis. IPV stimulates the production of polio-specific antibodies, not tetanus-specific antibodies.

C. Intradermal Tetanus Toxoid (ITT) is incorrect because, as mentioned before, ITT is less effective compared to Intramuscular Tetanus Toxoid (IM TT). Intramuscular administration ensures a higher concentration of tetanus toxoid at the site of action (muscle tissue) and accelerates the production of protective antibodies.

D. Intramuscular Inactivated Polio Vaccine (IPV) is incorrect because IPV is a different vaccine, not specifically designed for tetanus prophylaxis. IPV stimulates the production of polio-specific antibodies, not tetanus-specific antibodies.

**Clinical Pearls:**

1. Intramuscular administration of tetanus toxoid is crucial for effective tetanus prophylaxis, as intradermal administration of vaccines (such as IT